PATENT CLAIM ANALYSIS

Application Number: 16045937
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "175100"]

Abstract:
Low levels of antibodies reactive with oxidised Cardiolipin (oxCL) in mammals are related to an increased risk of developing cardivacular diseases, auto-immune diseases or inflammatory conditions. High levels can have a protective function and in general there is a negative association between manifestations of these conditions and antibodies against oxCL. Thus, based on their relations methods of monitoring, determining and diagnosing as well as methods of immunisation and therapy of these diseases and conditions are provided.

Claim (Index 26):
The method according to  claim 23 , wherein the Annexin A5 binds to oxCL.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 95.0
- Lexical Diversity: 1.44828
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13964581', '14155903', '15149969', '10599934', '14447782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7070778894387578
- 35 USC 102 Novelty (BERT): 0.5950069071759334
- Combined Prediction Score: 0.6958707912124754
- Mean Citation Score: 323.546512
- Max Citation Score: 601.41125
- Similarity Product: 389.2730723722279

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test